Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive …

BW Shiau, WH Hsu, YW Tsai, JY Wu… - Expert Review of Anti …, 2024 - Taylor & Francis
Objectives This study assessed the effectiveness of the oral antiviral agents nirmatrelvir–
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …

Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years

WH Hsu, BW Shiau, YW Tsai, JY Wu… - Expert Review of Anti …, 2024 - Taylor & Francis
Objective To investigate the effectiveness of oral antiviral agents–nirmatrelvir–ritonavir or
molnupiravir in non-hospitalized COVID-19 patients aged< 60 years. Methods This …

Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza

TH Liu, PY Huang, JY Wu, MH Chuang, WH Hsu… - BMC medicine, 2023 - Springer
Background Few studies have directly compared the risk and magnitude of post-acute
sequelae following COVID-19 and influenza, and most of these studies were conducted …

Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders

TH Liu, HY Liao, CC Chang, CC Lai - Frontiers in Pharmacology, 2024 - frontiersin.org
Objectives This study investigated the clinical effectiveness of molnupiravir for treating non-
hospitalized COVID-19 patients with pre-existing psychiatric disorder. Methods This …

The association between zinc deficiency, and clinical outcomes of COVID-19

JY Wu, WH Hsu, YW Tsai, TH Liu… - Journal of …, 2023 - journalofinfection.com
We read with great interest the systematic review and metaanalysis of the randomized
controlled trials conducted by Wu et al., which investigated the clinical efficacy of zinc (Zn) …

[HTML][HTML] The effect of bebtelovimab on clinical outcomes in patients with COVID-19: A meta-analysis

J Luo, A Li, C Liu, Y Wang, C Tran, G Ao - The Journal of Infection, 2023 - ncbi.nlm.nih.gov
We read the article in this journal by Hsu et al. with great interest regarding the effect of
molnupiravir on post-acute outcomes of patients with COVID-19 1. As we pass three years …

Learning from Post COVID-19 condition for epidemic preparedness: a variable catalogue for future Post-Acute Infection Syndromes

A Górska, LM Canziani, E Rinaldi, ZD Pana… - Clinical Microbiology …, 2024 - Elsevier
Abstract Scope The emergence of Post-COVID-19 Condition (PCC) following SARS-CoV-2
infection underscores the critical need for preparedness in addressing future Post-Acute …